In response to pathophysiologic stress or disease the adult heart undergoes hypertrophic enlargement such as concentric remodeling where individual adult cardiomyocytes primarily thicken. The heart can also undergo substantial dilation with more eccentric remodeling in response to different or progressive disease states in which myocytes more exclusively lengthen. These disease states involve neuroendocrine regulatory circuits initiated at the sarcolemma through G-protein coupled-receptors and receptor tyrosine kinases that in turn activate intermediate signal transduction pathways such as mitogen-activated protein kinases (MAPK). Previous literature indicates that each of the three major MAPK signaling branches (extracellular signal-regulated kinases [ERKs], c-Jun N-terminal kinases [JNKs] and p38) act as important regulators of cardiomyocyte growth dynamics. The myocyte itself is also thought to sense tension and/or stretch which can also initiate signal transduction, such as through the MAPK pathways to regulate growth. Past funding of this award focused on how MAPK signaling through GATA4/5/6 transcription factors regulated cardiac growth or dilation. We also previously showed that MEK1-ERK1/2 signaling specifically controls the decision of an adult cardiomyocyte to grow in width versus length. Here we propose an innovative renewal of this 19 year running award to mechanistically examine how myocytes respond to their environment and decide to grow in width versus length, and how this then impacts the remodeling of the entire 3-dimensional heart as either concentric or dilatory growth, such as in the familial hypertrophic (HCM) and dilated cardiomyopathies (DCM). Our 3 specific aims are 1) to define the cellular and molecular dynamics of MEK1-ERK1/2 in the heart and identify potential novel effectors of myocyte directional growth; 2) to perform a mechanistic interrogation of ERK1/2 targets as effectors of directional myocyte growth, and 3) to define the role of MEK1-ERK1/2 signaling in regulating myocyte directional growth in genetic models of HCM and DCM.

Public Health Relevance

The myocardium can hypertrophy in response to injury, changes in workload, or increases in wall stress, as well as due to genetic mutations in genes that encode sarcomeric proteins. In response to hypertrophic stimuli or tension alterations signaling pathways are activated that cause a fundamental reprogramming that results dimensional changes in myocyte growth. This application will attempt to identify novel effectors that mediate how the adult cardiac myocyte grows in width or length.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL060562-23
Application #
9963034
Study Section
Cardiac Contractility, Hypertrophy, and Failure Study Section (CCHF)
Program Officer
Adhikari, Bishow B
Project Start
1998-07-20
Project End
2022-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
23
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Khalil, Hadi; Maillet, Marjorie; Molkentin, Jeffery D (2017) Spatial Gene Profiling in the Ischemic Heart: Fibroblasts Put on Their SOX. Circulation 136:1410-1411
Kanisicak, Onur; Vagnozzi, Ronald J; Molkentin, Jeffery D (2017) Identity Crisis for Regenerative Cardiac cKit+ Cells. Circ Res 121:1130-1132
Cai, Chen-Leng; Molkentin, Jeffery D (2017) The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away. Circ Res 120:400-406
van Berlo, Jop H; Molkentin, Jeffery D (2016) Most of the Dust Has Settled: cKit+ Progenitor Cells Are an Irrelevant Source of Cardiac Myocytes In Vivo. Circ Res 118:17-9
Liu, Ruijie; Molkentin, Jeffery D (2016) Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs). J Mol Cell Cardiol 101:44-49
Karch, Jason; Molkentin, Jeffery D (2015) Regulated necrotic cell death: the passive aggressive side of Bax and Bak. Circ Res 116:1800-9
Kwong, Jennifer Q; Lu, Xiyuan; Correll, Robert N et al. (2015) The Mitochondrial Calcium Uniporter Selectively Matches Metabolic Output to Acute Contractile Stress in the Heart. Cell Rep 12:15-22
Auger-Messier, Mannix; Accornero, Federica; Goonasekera, Sanjeewa A et al. (2013) Unrestrained p38 MAPK activation in Dusp1/4 double-null mice induces cardiomyopathy. Circ Res 112:48-56
van Berlo, Jop H; Elrod, John W; van den Hoogenhof, Maarten M G et al. (2010) The transcription factor GATA-6 regulates pathological cardiac hypertrophy. Circ Res 107:1032-40
Wu, Xu; Eder, Petra; Chang, Baojun et al. (2010) TRPC channels are necessary mediators of pathologic cardiac hypertrophy. Proc Natl Acad Sci U S A 107:7000-5

Showing the most recent 10 out of 31 publications